BACE1 Dynamics Upon Inhibition with a BACE Inhibitor and Correlation to Downstream Alzheimer's Disease Markers in Elderly Healthy Participants
Overview
Neurology
Authors
Affiliations
The β-site amyloid-β protein precursor (AβPP) cleaving enzyme-1 (BACE1) is the rate limiting enzyme in the generation of amyloid-β peptide (Aβ) from AβPP, one of the major pathways in Alzheimer's disease (AD) pathology. Increased BACE1 levels and activity have been reported in the brain of patients with sporadic AD. Therefore, changes of BACE1 levels in the cerebrospinal fluid (CSF) have also been investigated as a possible biomarker of the disease. We analyzed BACE1 levels in CSF of elderly healthy participants before and after chronic treatment with a BACE inhibitor (BACEi) and evaluated the correlation between BACE1 levels and downstream AD markers. Overall, BACE1 CSF levels showed strong correlations to all downstream AD markers investigated. This is the first reported finding that shows BACE1 levels in CSF were well correlated to its end product Aβ1 - 42. As previously described, BACE1 levels were strongly correlated to total-tau and phosphorylated tau levels in CSF. Generally, chronic BACE inhibition did not influence BACE1 CSF protein levels. Follow-up studies including early-stage AD pathophysiology and prodromal AD patients will help to understand the importance of measuring BACE1 routinely in daily clinical practice and AD clinical trials.
Review on anti-alzheimer drug development: approaches, challenges and perspectives.
Abdallah A RSC Adv. 2024; 14(16):11057-11088.
PMID: 38586442 PMC: 10995770. DOI: 10.1039/d3ra08333k.
BACE1 Inhibitors for Alzheimer's Disease: The Past, Present and Any Future?.
Bazzari F, Bazzari A Molecules. 2022; 27(24).
PMID: 36557955 PMC: 9785888. DOI: 10.3390/molecules27248823.
P-tau subgroups in AD relate to distinct amyloid production and synaptic integrity profiles.
Wesenhagen K, Tijms B, Boonkamp L, Hoede P, Goossens J, Dewit N Alzheimers Res Ther. 2022; 14(1):95.
PMID: 35841015 PMC: 9288016. DOI: 10.1186/s13195-022-01038-z.
Zhang T, Liu N, Wei W, Zhang Z, Li H Oxid Med Cell Longev. 2021; 2021:9918498.
PMID: 34367470 PMC: 8339876. DOI: 10.1155/2021/9918498.
Onset of Preclinical Alzheimer Disease in Monozygotic Twins.
Konijnenberg E, Tomassen J, den Braber A, Ten Kate M, Yaqub M, Mulder S Ann Neurol. 2021; 89(5):987-1000.
PMID: 33583080 PMC: 8251701. DOI: 10.1002/ana.26048.